Pre-Clinical SARMs: News in Muscle and Bone Health Research
Pre-clinical Selective Androgen Receptor Modulators (SARMs) are investigational compounds attracting interest for their muscle and bone-enhancing potential with fewer side effects than steroids. These compounds selectively target androgen receptors, promoting growth without affecting organs like the liver and prostate. While promising in early studies for conditions like muscle wasting, extensive research is needed to establish their safety and efficacy in humans before they can be widely used in therapy.

